BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 2847826)

  • 21. Calcium antagonists, ventricular fibrillation, and enzyme release in ischemic rat hearts.
    Opie LH; Thandroyen FT
    Fed Proc; 1983 May; 42(8):2465-9. PubMed ID: 6132839
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Change in opioid peptide level in the heart and blood plasma during acute myocardial ischaemia complicated by ventricular fibrillation.
    Maslov LN; Lishmanov YB
    Clin Exp Pharmacol Physiol; 1995 Nov; 22(11):812-6. PubMed ID: 8593735
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Mechanisms contributing to malignant dysrhythmias induced by ischemia in the cat.
    Corr PB; Witkowski FX; Sobel BE
    J Clin Invest; 1978 Jan; 61(1):109-19. PubMed ID: 201667
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Femtomole sensitive radioimmunoassay for cyclic AMP and cyclic GMP after 2'0 acetylation by acetic anhydride in aqueous solution.
    Harper JF; Brooker G
    J Cyclic Nucleotide Res; 1975; 1(4):207-18. PubMed ID: 177461
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Heart failure reduces both the effects and interaction between cyclic GMP and cyclic AMP.
    Moalem J; Weiss HR; Davidov T; Rodriguez R; Molino B; Lazar MJ; Scholz PM
    J Surg Res; 2006 Aug; 134(2):300-6. PubMed ID: 16545395
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Anti-arrhythmic action of adenosine and the cyclic nucleotide content of the myocardium of rats with ischemia].
    Eliseev VV; Poltavchenko GM; Evdokimova NR; Sokolova EN; Ovchinnikova AG
    Biull Eksp Biol Med; 1987 Jul; 104(7):43-5. PubMed ID: 3040145
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Cyclic GMP and cyclic AMP induced changes in control and hypertrophic cardiac myocyte function interact through cyclic GMP affected cyclic-AMP phosphodiesterases.
    Weiss HR; Gong GX; Straznicka M; Yan L; Tse J; Scholz PM
    Can J Physiol Pharmacol; 1999 Jun; 77(6):422-31. PubMed ID: 10537228
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Dynamics of the cAMP and cGMP content of the heart in transient coronary insufficiency in rats].
    Litvitskiĭ PF; Vinnitskiĭ LI; Zhidkov IL; Zuev MB; Vorob'eva NT
    Biull Eksp Biol Med; 1984 Jan; 97(1):37-9. PubMed ID: 6318860
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Enkephalin and cyclic nucleotide content in the brain structures of rats at different stages of the formation and development of alcoholic dependence].
    Balakleevskiĭ AI; Maslova IV; Petrenko SV; Surikov PM
    Biull Eksp Biol Med; 1986 Mar; 101(3):291-4. PubMed ID: 3006825
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Ventricular fibrillation frequency characteristics are altered in acute myocardial infarction.
    Indik JH; Donnerstein RL; Berg RA; Hilwig RW; Berg MD; Kern KB
    Crit Care Med; 2007 Apr; 35(4):1133-8. PubMed ID: 17334241
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Cyclic nucleotides of human and animal glial tumors].
    Shmidt TE; Khokhlov AP; Malakhovskiĭ VK; Promyslov MSh; Levchenko LI
    Biull Eksp Biol Med; 1980 Apr; 89(4):454-7. PubMed ID: 6248150
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effects of coronary vasodilator on cyclic nucleotides. The concentrations of cyclic AMP and cyclic GMP in canine coronary artery and left ventricular muscle following the administration of various coronary vasodilators.
    Kobayashi A; Ogawa K
    Jpn Circ J; 1979 Dec; 43(12):1132-4. PubMed ID: 232193
    [No Abstract]   [Full Text] [Related]  

  • 33. [Cyclic Amp(cAMP), cyclic GMP (cGMP)].
    Okuya S
    Nihon Rinsho; 2010 Jul; 68 Suppl 7():651-5. PubMed ID: 20963901
    [No Abstract]   [Full Text] [Related]  

  • 34. [Several pathogenetic factors of experimental "indomethacin" hypertension].
    Sokolova RI; Speranskaia NV; Vikhert AM
    Biull Eksp Biol Med; 1978 Aug; 86(8):150-3. PubMed ID: 210860
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Postmortem diagnosis of ventricular fibrillation in acute coronary insufficiency].
    Aleksandri AL; Bezprozvannyĭ BK
    Kardiologiia; 1984 Dec; 24(12):62-5. PubMed ID: 6521229
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Stimulation of delta1-opioid receptors increases the ventricular fibrillation threshold in post-infarct cardiosclerosis: the role of K(ATP)-channels].
    Solenkova NV; Maslov LN; Lishmanov IuB; Serebrov VIu; Bogomaz SA; Gross GG; Stefano JB; Tam SV
    Eksp Klin Farmakol; 2002; 65(1):30-3. PubMed ID: 12025781
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effects of diltiazem upon experimental ventricular dysrhythmias.
    Patterson E; Eller BT; Lucchesi BR
    J Pharmacol Exp Ther; 1983 Apr; 225(1):224-33. PubMed ID: 6834274
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Recurrent ventricular fibrillation in acute myocardial infarct treated successfully by coronary angioplasty: a clinical case in favor of the hypothesis of the arrhythmogenicity of the coronary thrombus?].
    Trabattoni D; Bartorelli AL
    Cardiologia; 1998 Oct; 43(10):1095-9. PubMed ID: 9922575
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Characteristics of the changes in the intra- and extracellular K+ and Na+ concentrations and the intra- and extracellular pH in the area of cardiac ishemia in experimental myocardial infarct complicated by ventricular fibrillation].
    Veksler VI
    Kardiologiia; 1979 Oct; 19(10):88-91. PubMed ID: 41134
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Progressive decrease of the causes that maintain ventricular fibrillation after experimental coronary occlusion].
    Lanari A; Serur J
    Medicina (B Aires); 1965; 25(6):341-4. PubMed ID: 15154227
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.